![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Found 75 studies with search of: | "Tipifarnib" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Completed |
Zarnestra and Gleevec in Chronic Phase Chronic Myelogenous Leukemia
|
||||
2 | Completed |
Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer
|
||||
3 | Completed |
Study of Tipifarnib in Patients With High-Risk Myelodysplastic Syndrome (MDS)
|
||||
4 | Completed |
Study of Tipifarnib as Postconsolidation Therapy for Acute Myeloid Leukemia in Patients 60 Years and Older
|
||||
5 | Completed |
Tipifarnib Versus Best Supportive Care in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
|
||||
6 | Completed |
A Phase 2 Study of Farnesyl Transferase Inhibitor (R115777, Tipifarnib) in Patients With Refractory or Relapsed Acute Myeloid Leukemia.
|
||||
7 | Terminated |
Efficacy and Safety of the Farnesyl-Transferase Inhibitor (Tipifarnib) in Mantle Cell Lymphoma
|
||||
8 | Active, not recruiting |
Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
|
||||
9 | Recruiting |
Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast Cancer
|
||||
10 | Active, not recruiting |
Response to Tipifarnib in Individuals With Large Granular Lymphocyte Leukemia
|
||||
11 | Recruiting |
Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid Leukemia
|
||||
12 | Active, not recruiting |
Capecitabine and Tipifarnib in Treating Women With Taxane-Resistant Metastatic Breast Cancer
|
||||
13 | Active, not recruiting |
Tipifarnib and Fulvestrant as Second-Line Therapy in Treating Postmenopausal Women With Hormone Receptor-Positive Inoperable Locally Advanced or Metastatic Breast Cancer With Progressive Disease After Previous First-Line Endocrine Therapy
|
||||
14 | Suspended |
Tipifarnib and Gemcitabine in Treating Women With Metastatic Breast Cancer
|
||||
15 | Completed |
Tipifarnib Plus Tamoxifen in Treating Women With Metastatic Breast Cancer
|
||||
16 | Suspended |
Tipifarnib and Sorafenib in Treating Patients With Advanced Cancer
|
||||
17 | Completed |
Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer
|
||||
18 | Active, not recruiting |
Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia
|
||||
19 | Recruiting |
Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase
|
||||
20 | Terminated |
A Combination of Zarnestra With Velcade for Patients With Relapsed Multiple Myeloma
|
![]() |
Previous Page | Studies Shown (1-20) | Next Page (21-40) |
![]() |